Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease
Abstract
Background & aims Around 10-20% of patients with non-alcoholic fatty liver disease (NAFLD) are non-obese. The benefit of weight reduction in such patients is unclear. We aim to study the efficacy of lifestyle intervention in non-obese patients with NAFLD and to identify factors that predict treatment response.Methods A total of 154 community NAFLD patients were randomised to a 12-month lifestyle intervention programme involving regular exercise, or to standard care. The primary outcome was remission of NAFLD at Month 12 by proton-magnetic resonance spectroscopy. After the programme, the patients were prospectively followed until Year 6. The Asian body mass index (BMI) cut-off of 25 kg/m 2 was used to define non-obese NAFLD.Results Patients were assigned to the intervention (n = 77) and control (n = 77) groups (39 and 38 in each group had baseline BMI <25 and ≥25 kg/m 2, respectively). More patients in the intervention group achieved the primary outcome than the control group regardless of baseline BMI (non-obese: 67% vs. 18%, p <0.001; obese: 61% vs. 21%, p <0.001). Lifestyle intervention, lower baseline intrahepatic triglyceride, and reduction in body weight and waist circumference were independent factors associated with remission of NAFLD in non-obese patients. Half of non-obese patients achieved remission of NAFLD with 3-5% weight reduction; the same could only be achieved in obese patients with 7-10% weight reduction. By Year 6, non-obese patients in the intervention group remained more likely to maintain weight reduction and alanine aminotransferase normalisation than the control group.Conclusions Lifestyle intervention is effective in treating NAFLD in both non-obese and obese patients. Weight reduction predicts remission of NAFLD in non-obese patients, but a modest weight reduction may be sufficient in this population.Lay summary Some patients with non-alcoholic fatty liver disease (NAFLD) are non-obese. The optimal management of such patients is unclear. In this long-term follow-up study of a clinical trial, we show that remission of NAFLD can be achieved in 67% of non-obese patients after lifestyle intervention. The majority of patients can achieve NAFLD remission with modest weight loss of 3-10%. Non-obese patients are also more likely than obese patients to maintain weight reduction and normal liver enzymes in the long run.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In an RCT of a 12-month lifestyle intervention programme, a 3-5% weight reduction led to remission of MASLD (measured by 1H-MRS) among 50% of the individuals without obesity.
“In an RCT of a 12month lifestyle intervention programme, a 3-5% weight reduction led to remission of MASLD (measured by 1 H-MRS) among 50% of the individuals without obesity.”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [333]
Individuals defined as non-obese were more likely than individuals with obesity to maintain weight reduction and normal liver enzymes over long-term (6-year) follow-up.
“Moreover, individuals de fi ned as non-obese were more likely than individuals with obesity to maintain weight reduction and normal liver enzymes over long-term (6-year) follow-up. 333”
From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [333]
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works
Wai, C.-T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., & Lok, A. S.-F. (2003) · Hepatology · doi:10.1053/jhep.2003.50346 · Cited by 4,406 · see citing works
Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,054 · see citing works
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908 · see citing works
Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., Friedman, S. L., Diago, M., & Romero-Gomez, M. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.005 · Cited by 2,492 · see citing works
Long-term weight loss maintenance
Wing, R. R., & Phelan, S. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.1.222s · Cited by 1,941 · see citing works
Franz, M. J., VanWormer, J. J., Crain, A. L., Boucher, J. L., Histon, T., Caplan, W., Bowman, J. D., & Pronk, N. P. (2007) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2007.07.017 · Cited by 1,559 · see citing works
Treatment of NAFLD with diet, physical activity and exercise
Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.016 · Cited by 1,347 · see citing works
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330 · see citing works
Wong, V. W.-S., Vergniol, J., Wong, G. L.-H., Foucher, J., Chan, H. L.-Y., Le Bail, B., Choi, P. C.-L., Kowo, M., Chan, A. W.-H., Merrouche, W., et al. (2010) · Hepatology · doi:10.1002/hep.23312 · Cited by 1,322 · see citing works
New trends on obesity and NAFLD in Asia
Fan, J.-G., Kim, S. U., & Wong, V. W. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.06.003 · Cited by 1,088 · see citing works
Cusi, K., Orsak, B., Bril, F., Lomonaco, R., Hecht, J., Ortiz-Lopez, C., Tio, F., Hardies, J., Darland, C., Musi, N., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1774 · Cited by 1,024 · see citing works
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911 · see citing works
Ryan, M. C., Itsiopoulos, C., Thodis, T., Ward, G., Trost, N., Hofferberth, S., O’Dea, K., Desmond, P. V., Johnson, N. A., & Wilson, A. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.012 · Cited by 778 · see citing works
Nonalcoholic fatty liver disease
Brunt, E., Wong, V., Nobili, V., Day, C., Sookoian, S., Maher, J., Bugianesi, E., Sirlin, C., Neuschwander-Tetri, B., & Rinella, M. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.80 · Cited by 591 · see citing works
Thoma, C., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.06.010 · Cited by 523 · see citing works
Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review
Hashida, R., Kawaguchi, T., Bekki, M., Omoto, M., Matsuse, H., Nago, T., Takano, Y., Ueno, T., Koga, H., George, J., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.023 · Cited by 509 · see citing works
Wong, V. W., Chu, C. W., Wong, G. L., Chan, R., Chim, A. M., Ong, A., Yeung, D. K., Yiu, K. K., Chu, S. H.-T., Woo, J., et al. (2011) · Gut · doi:10.1136/gutjnl-2011-300342 · Cited by 491 · see citing works
Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease
Nobili, V., Manco, M., Vito, R. D., Ciommo, V. M. D., Comparcola, D., Sartorelli, M. R., Piemonte, F., Marcellini, M., & Angulo, P. (2008) · Hepatology · doi:10.1002/hep.22336 · Cited by 412 · see citing works
Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients
Leung, J. C., Loong, T. C., Wei, J. L., Wong, G. L., Chan, A. W. H., Choi, P. C., Shu, S. S., Chim, A. M., Chan, H. L., & Wong, V. W. (2016) · Hepatology · doi:10.1002/hep.28697 · Cited by 348 · see citing works
Wong, V. W., Chan, R., Wong, G. L., Cheung, B., Chu, C. W., Yeung, D. K., Chim, A. M., Lai, J. W.-Y., Li, L. S., Sea, M. M.-M., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.013 · Cited by 346 · see citing works
Kim, D., & Kim, W. R. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.08.028 · Cited by 341 · see citing works
Wei, J. L., Leung, J. C., Loong, T. C., Wong, G. L., Yeung, D. K., Chan, R., Chan, H. L., Chim, A. M., Woo, J., Chu, C. W., et al. (2015) · The American Journal of Gastroenterology · doi:10.1038/ajg.2015.235 · Cited by 317 · see citing works
Haufe, S., Engeli, S., Kast, P., Böhnke, J., Utz, W., Haas, V., Hermsdorf, M., Mähler, A., Wiesner, S., Birkenfeld, A. L., et al. (2011) · Hepatology · doi:10.1002/hep.24242 · Cited by 307 · see citing works
Sullivan, S. A., Kirk, E. P., Mittendorfer, B., Patterson, B. W., & Klein, S. (2011) · Hepatology · doi:10.1002/hep.25548 · Cited by 303 · see citing works
High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis
Wong, V. W., Wong, G. L., Tsang, S. W., Fan, T., Chu, C. W., Woo, J., Chan, A. W. H., Choi, P. C. L., Chim, A. M.-L., Lau, J. Y. W., et al. (2011) · Gut · doi:10.1136/gut.2011.237974 · Cited by 254 · see citing works
Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver
Feldman, A., Eder, S. K., Felder, T. K., Kedenko, L., Paulweber, B., Stadlmayr, A., Huber-Schönauer, U., Niederseer, D., Stickel, F., Auer, S., et al. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.318 · Cited by 239 · see citing works
Sookoian, S., & Pirola, C. J. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14112 · Cited by 230 · see citing works
Bozzetto, L., Prinster, A., Annuzzi, G., Costagliola, L., Mangione, A., Vitelli, A., Mazzarella, R., Longobardo, M., Mancini, M., Vigorito, C., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0033 · Cited by 227 · see citing works
Normal weight individuals who develop Type 2 diabetes: the personal fat threshold
Taylor, R., & Holman, R. R. (2014) · Clinical Science · doi:10.1042/cs20140553 · Cited by 190 · see citing works
Wong, V. W., Wong, G. L., Yeung, D. K., Lau, T. K., Chan, C. K.-M., Chim, A. M., Abrigo, J., Chan, R., Woo, J., Tse, Y., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.08.041 · Cited by 173 · see citing works
George, A. S., Bauman, A. E., Johnston, A., Farrell, G. C., Chey, T., & George, J. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05694.x · Cited by 117 · see citing works
Sookoian, S. C., & Pirola, C. J. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14401 · Cited by 103 · see citing works
Wong, V. W., Hui, A., Tsang, S. W., Chan, J. L.-Y., Wong, G. L., Chan, A. W. H., So, W., CHENG, A. Y. S., Tong, P. C. Y., Chan, F. K. L., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03112.x · Cited by 92 · see citing works
de Luis, D. A., Aller, R., Izaola, O., Sagrado, M. G., & Conde, R. (2010) · PubMed · Cited by 70 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667 · see citing works
Tacke, F., Horn, P., Wai-Sun Wong, V., Ratziu, V., Bugianesi, E., Francque, S., Zelber-Sagi, S., Valenti, L., Roden, M., Schick, F., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.04.031 · Cited by 2,210 · see citing works
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Aron‐Wisnewsky, J., Vigliotti, C., Witjes, J. J., Le, P. T., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,085 · see citing works
Eslam, M., Sarin, S. K., Wong, V. W., Fan, J.-G., Kawaguchi, T., Ahn, S. H., Zheng, M., Shiha, G. E.-S., Yilmaz, Y. N., Gani, R. A., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10094-2 · Cited by 837 · see citing works
Younossi, Z. M., Corey, K. E., & Lim, J. K. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.051 · Cited by 503 · see citing works
(2024) · Obesity Facts · doi:10.1159/000539371 · Cited by 510 · see citing works
Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
Li, R., Zou, J., Ran, W., Qi, X., Chen, Y., Cui, H., & Guo, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1087260 · Cited by 338 · see citing works
Metabolic dysfunction-associated steatotic liver disease in adults
Huang, D. Q., Wong, V. W., Rinella, M. E., Boursier, J., Lazarus, J. V., Yki‐Järvinen, H., & Loomba, R. S. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00599-1 · Cited by 336 · see citing works
Long, M. T., Noureddin, M., & Lim, J. K. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.023 · Cited by 299 · see citing works
Lifestyle interventions in nonalcoholic fatty liver disease
Younossi, Z. M., Zelber-Sagi, S., Henry, L., & Gerber, L. H. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00800-4 · Cited by 281 · see citing works
Koutoukidis, D. A., Astbury, N. M., Tudor, K., Morris, E. M., Henry, J. A., Noreik, M., Jebb, S. A., & Aveyard, P. N. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.2248 · Cited by 270 · see citing works
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Kang, S. H., Lee, H. W., Yoo, J., Cho, Y., Kim, S. U., Lee, T. H., Jang, B. K., Ahn, S. B., Ahn, S. B., Kim, H., et al. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0178 · Cited by 271 · see citing works
Lifestyle modification in NAFLD/NASH: Facts and figures
Hallsworth, K., & Adams, L. A. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.10.008 · Cited by 266 · see citing works
Non-alcoholic fatty liver disease: A patient guideline
Francque, S. M., Marchesini, G., Kautz, A., Walmsley, M., Dorner, R., Lazarus, J. V., Zelber-Sagi, S., Hallsworth, K., Busetto, L., Frühbeck, G., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100322 · Cited by 264 · see citing works
Zou, B., Yeo, Y. H., Nguyen, V. H., Cheung, R. C., Ingelsson, E., & Nguyen, M. H. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13069 · Cited by 250 · see citing works
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Lee, K., Wu, P.-S., & Lin, H. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0237 · Cited by 260 · see citing works
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
Eslam, M., El‐Serag, H. B., Francque, S., Sarin, S. K., Wei, L., Bugianesi, E., & George, J. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00635-5 · Cited by 246 · see citing works
Impact of Nutritional Changes on Nonalcoholic Fatty Liver Disease
Perdomo, C. M., Frühbeck, G., & Escalada, J. (2019) · Nutrients · doi:10.3390/nu11030677 · Cited by 217 · see citing works
Treatments for NAFLD: State of Art
Mantovani, A., & Dalbeni, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052350 · Cited by 202 · see citing works
Wong, V. W., Wong, G. L., Woo, J., Abrigo, J., Chan, C. K.-M., Shu, S. S., Leung, J. K., Chim, A. M., Kong, A. P. S., Lui, G. C.-Y., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.10.046 · Cited by 192 · see citing works
Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
Tana, C., Ballestri, S., Ricci, F., Vincenzo, A. D., Ticinesi, A., Gallina, S., Giamberardino, M. A., Cipollone, F., Sutton, R., Vettor, R., et al. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16173104 · Cited by 191 · see citing works
Younossi, Z. M., Zelber-Sagi, S., Lazarus, J. V., Wong, V. W.-S., Yilmaz, Y., Duseja, A., Eguchi, Y., Castera, L., Pessoa, M. G., Oliveira, C. P., et al. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.02.044 · Cited by 194 · see citing works
Management of non-alcoholic fatty liver disease
Petroni, M. L., Brodosi, L., Bugianesi, E., & Marchesini, G. (2021) · BMJ · doi:10.1136/bmj.m4747 · Cited by 181 · see citing works
Obesity in South and Southeast Asia—A new consensus on care and management
Tham, K. W., Abdul Ghani, R., Cua, S. C., Deerochanawong, C., Fojas, M., Hocking, S., Lee, J., Nam, T. Q., Pathan, F., Saboo, B., et al. (2023) · Obesity Reviews · doi:10.1111/obr.13520 · Cited by 187 · see citing works
A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe
Lazarus, J. V., Ekstedt, M., Marchesini, G., Mullen, J., Novak, K., Pericàs, J. M., Roel, E., Romero‐Gómez, M., Ratziu, V., Tacke, F., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.027 · Cited by 167 · see citing works
Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants
Rives, C., Fougerat, A., Ellero‐Simatos, S., Loiseau, N., Guillou, H., Gamet‐Payrastre, L., & Wahli, W. (2020) · Biomolecules · doi:10.3390/biom10121702 · Cited by 160 · see citing works
Fougerat, A., Montagner, A., Loiseau, N., Guillou, H., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071638 · Cited by 147 · see citing works
Geographical similarity and differences in the burden and genetic predisposition of NAFLD
Yip, T. C., Gómez, E. V., Petta, S., Yilmaz, Y. N., Wong, G. L., Adams, L. A., de Lédinghen, V., Sookoian, S. C., & Wong, V. W. (2022) · Hepatology · doi:10.1002/hep.32774 · Cited by 123 · see citing works
Keating, S. E., Sabag, A., Hallsworth, K., Hickman, I. J., Macdonald, G. A., Stine, J. G., George, J., & Johnson, N. A. (2023) · Sports Medicine · doi:10.1007/s40279-023-01918-w · Cited by 119 · see citing works
Fernández, T., Viñuela, M., Vidal, C., & Barrera, F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263931 · Cited by 117 · see citing works
Exercise Combats Hepatic Steatosis: Potential Mechanisms and Clinical Implications
Thyfault, J. P., & Rector, R. S. (2020) · Diabetes · doi:10.2337/dbi18-0043 · Cited by 111 · see citing works
Cui, D., Yu, X., Guan, Q., Shen, Y., Liao, J., Liu, Y., & Su, Z. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00321-3 · Cited by 120 · see citing works
Roeb, E., Canbay, A. E., Tacke, F., Bantel, H., Bojunga, J., de Laffolie, J., Demir, M., Denzer, U. W., Geier, A., Hofmann, W. P., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1880-2283 · Cited by 102 · see citing works
Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
Kuchay, M. S., Martínez‐Montoro, J. I., Choudhary, N. S., Fernández‐García, J. C., & Ramos‐Molina, B. (2021) · Biomedicines · doi:10.3390/biomedicines9101346 · Cited by 103 · see citing works
Xu, R., Pan, J., Zhou, W., Ji, G., & Dang, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113331 · Cited by 97 · see citing works
MAFLD enhances clinical practice for liver disease in the Asia-Pacific region
Kawaguchi, T., Tsutsumi, T., Nakano, D., Eslam, M., George, J., & Torimura, T. (2021) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0310 · Cited by 92 · see citing works
Pydyn, N., Miękus, K., Jura, J., & Kotlinowski, J. (2020) · Pharmacological Reports · doi:10.1007/s43440-019-00020-1 · Cited by 87 · see citing works
Emerging role of genomic analysis in clinical evaluation of lean individuals with NAFLD
Vilarinho, S., Ajmera, V., Zheng, M., & Loomba, R. (2021) · Hepatology · doi:10.1002/hep.32047 · Cited by 85 · see citing works
Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease
Schaapman, J. J., Tushuizen, M. E., Coenraad, M. J., & Lamb, H. J. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27292 · Cited by 85 · see citing works
Effects of Periodic Fasting on Fatty Liver Index—A Prospective Observational Study
Drinda, S., Grundler, F., Neumann, T. E., Lehmann, T., Steckhan, N., Michalsen, A., & de Toledo, F. W. (2019) · Nutrients · doi:10.3390/nu11112601 · Cited by 85 · see citing works
Association of genetic variations with NAFLD in lean individuals
Lin, H., Wong, G. L., Whatling, C. A., Chan, A. W. H., Leung, H. H. W., Tse, C., Shu, S. S., Chim, A. M.-L., Lai, J. C., Yip, T. C., et al. (2021) · Liver International · doi:10.1111/liv.15078 · Cited by 80 · see citing works
Lu, S., Xie, Q., Kuang, M., Hu, C., Li, X., Yang, H., Sheng, G., Xie, G., & Zou, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04047-0 · Cited by 79 · see citing works
Fan, J., Xu, X., Yang, R.-X., Nan, Y., Wei, L., Jia, J., Zhuang, H., Shi, J., Li, X., Cm, S., et al. (2024) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00311 · Cited by 85 · see citing works
Ivashkin, V. T., Maevskaya, M. V., Жаркова, М. С., Kotovskaya, Y. V., Ткачева, О. Н., Troshina, E. A., Shestakova, M. V., Maev, I. V., Breder, V. V., Geyvandova, N. I., et al. (2022) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2022-32-4-104-140 · Cited by 85 · see citing works
Lee, B., Lee, Y., Park, C., Rhee, E., Lee, W., Kim, N. H., Choi, K. M., Park, K., Choi, Y., Soo, B., et al. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0010 · Cited by 77 · see citing works
Maestri, M., Santopaolo, F., Pompili, M., Gasbarrini, A., & Ponziani, F. R. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1110536 · Cited by 76 · see citing works
Zhang, L. R., Wang, Y., Wu, F., Wang, X., Feng, Y., & Wang, Y. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.036 · Cited by 73 · see citing works
Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease
Lin, H., Zhang, X., Li, G., Wong, G. L.-H., & Wong, V. W.-S. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00201 · Cited by 68 · see citing works
Parra-Vargas, M., Rodriguez‐Echevarría, R., & Jiménez‐Chillarón, J. C. (2020) · Nutrients · doi:10.3390/nu12123860 · Cited by 63 · see citing works
Kim, H., Bae, S., Lee, M. J., Kim, E. H., Park, H., Kim, H. S., Cho, Y. K., Jung, C. H., Lee, W. J., & Choe, J. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0035 · Cited by 61 · see citing works
Maevskaya, M. V., Kotovskaya, Y. V., Ivashkin, V. T., Ткачева, О. Н., Troshina, E. A., Shestakova, M. V., Breder, V. V., Geyvandova, N. I., Doshchitsin, V. L., Dudinskaya, Е. N., et al. (2022) · Terapevticheskii arkhiv · doi:10.26442/00403660.2022.02.201363 · Cited by 65 · see citing works
Hamurcu, P., Kaya, E., Alphan, E., & Yilmaz, Y. N. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001656 · Cited by 60 · see citing works
Comparison between obese and non-obese nonalcoholic fatty liver disease
Chan, W. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0350 · Cited by 58 · see citing works
Zhang, X., Goh, G. B., Chan, W., Wong, G. L., Fan, J., Seto, W., Huang, Y., Lin, H., Lee, I., Lee, H. W., et al. (2020) · Liver International · doi:10.1111/liv.14638 · Cited by 58 · see citing works
Alferink, L. J. M., Erler, N. S., de Knegt, R. J., Janssen, H. L. A., Metselaar, H. J., Murad, S. D., & Jong, J. C. K. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00627-2 · Cited by 55 · see citing works
Huang, S., Su, H.-J., Kao, J., Tseng, T., Yang, H., Su, T., Chen, P., & Liu, C. (2021) · Gut and Liver · doi:10.5009/gnl20218 · Cited by 54 · see citing works
Danpanichkul, P., Suparan, K., Kim, D., & Wijarnpreecha, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13010278 · Cited by 54 · see citing works
Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
Kim, K., Lee, B., Kim, Y. J., Lee, D. H., Soo, B., & Park, C. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0034 · Cited by 53 · see citing works
Chen, V. L., Du, X., Oliveri, A., Chen, Y., Kuppa, A., Halligan, B. D., Province, M. A., & Speliotes, E. K. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.03.045 · Cited by 52 · see citing works
Obesity Without Metabolic Abnormality and Incident CKD: A Population-Based British Cohort Study
Wang, J., Niratharakumar, K., Gokhale, K. M., Tahrani, A. A., Taverner, T., Thomas, G. N., & Dasgupta, I. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.05.008 · Cited by 50 · see citing works
One size does not fit all; practical, personal tailoring of the diet to <scp>NAFLD</scp> patients
Zelber‐Sagi, S., Grinshpan, L. S., Ivancovsky‐Wajcman, D., Goldenshluger, A., & Gepner, Y. (2022) · Liver International · doi:10.1111/liv.15335 · Cited by 49 · see citing works
Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review
Parry, S. A., & Hodson, L. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01281-6 · Cited by 50 · see citing works
NAFLD and Physical Exercise: Ready, Steady, Go!
Berković, M. C., Bilić-Čurčić, I., Mrzljak, A., & Cigrovski, V. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.734859 · Cited by 49 · see citing works
Lee, C., Han, K., Kim, D. H., & Kwak, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.638615 · Cited by 47 · see citing works
Fouad, Y. M., Esmat, G., Elwakil, R., Zakaria, S., Yosry, A., Waked, I. A., El-Razky, M., Doss, W. H., El‐Serafy, M., Mostafa, E., et al. (2022) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_357_21 · Cited by 48 · see citing works
Non‐alcoholic fatty liver disease and psoriasis – is there a shared proinflammatory network?
Heitmann, J., Frings, V. G., Geier, A., Goebeler, M., & Kerstan, A. (2021) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14425 · Cited by 47 · see citing works
Lifestyle modifications for non-alcohol related fatty liver disease: a network meta-analysis
Buzzetti, E., Linden, A. H., Best, L. M., Madden, A. M., Roberts, D. A., Chase, T. J. G., Freeman, S. C., Cooper, N. J., Sutton, A. J., Fritche, D., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013156 · Cited by 48 · see citing works
Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes
Finer, N. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14569 · Cited by 45 · see citing works
Ng, S. S., Wong, V. W., Wong, G. L., Chu, C. W., Chan, T., To, K., Ko, F. W. S., Chan, K.-P., & Hui, D. S. C. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202005-1868oc · Cited by 45 · see citing works
Lean nonalcoholic fatty liver disease and sarcopenia
Chen, M., Cao, Y. Y., Ji, G., & Zhang, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217249 · Cited by 45 · see citing works
Changing clinical management of NAFLD in Asia
Nakatsuka, T., Tateishi, R., & Koike, K. (2021) · Liver International · doi:10.1111/liv.15046 · Cited by 44 · see citing works
Keating, S. E., Chawla, Y. K., De, A., & George, E. S. (2024) · Hepatology International · doi:10.1007/s12072-024-10663-9 · Cited by 43 · see citing works
Treatment Candidacy for Pharmacologic Therapies for NASH
Rowe, I. A., Wong, V. W.-S., & Loomba, R. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.03.005 · Cited by 41 · see citing works
Kamada, Y., Takahashi, H., Shimizu, M., Kawaguchi, T., Sumida, Y., Fujii, H., Seko, Y., Fukunishi, S., Tokushige, K., Nakajima, A., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01833-9 · Cited by 40 · see citing works
Yoshioka, N., Ishigami, M., Watanabe, Y., Sumi, H., Doisaki, M., Yamaguchi, T., Ito, T., Ishizu, Y., Kuzuya, T., Honda, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57369-9 · Cited by 39 · see citing works
Sinn, D. H., Kang, D., Cho, S. J., Paik, S. W., Guallar, E., Cho, J., & Gwak, G.-Y. (2021) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002158 · Cited by 37 · see citing works
Li, M., Cui, M., Li, G., Liu, Y., Xu, Y., Eftekhar, S. P., & Ala, M. (2024) · Hormone and Metabolic Research · doi:10.1055/a-2266-1503 · Cited by 37 · see citing works
de Souza, M. H. G., Diaz, I., & Al‐Sharif, L. (2024) · Hepatology International · doi:10.1007/s12072-024-10716-z · Cited by 37 · see citing works
Marchesini, G., Bugianesi, E., Burra, P., Marra, F., Miele, L., Alisi, A., Vajro, P., Masarone, M., Petta, S., Persico, M., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.04.028 · Cited by 35 · see citing works
Hadefi, A., Arvanitakis, M., Trépo, E., & Zelber‐Sagi, S. (2023) · United European Gastroenterology Journal · doi:10.1002/ueg2.12443 · Cited by 37 · see citing works
Key takeaways from the updated multidisciplinary European MASLD guidelines
Horn, P., & Tacke, F. (2025) · eGastroenterology · doi:10.1136/egastro-2025-100196 · Cited by 37 · see citing works
The metabolic profiles and body composition of lean metabolic associated fatty liver disease
Cheng, Y., Kao, J., & Wang, C. (2021) · Hepatology International · doi:10.1007/s12072-021-10147-0 · Cited by 35 · see citing works
Ali, H., Shahzil, M., Moond, V., Shahzad, M., Thandavaram, A., Sehar, A., Waseem, H., Siddiqui, T. A., Dahiya, D. S., Patel, P., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14010061 · Cited by 34 · see citing works
Practical Lifestyle Management of Nonalcoholic Fatty Liver Disease for Busy Clinicians
Zelber‐Sagi, S., & Moore, J. B. (2024) · Diabetes Spectrum · doi:10.2337/dsi23-0009 · Cited by 34 · see citing works
Fang, L., Li, J., Zeng, H., & Liu, J. (2024) · Primary Care Diabetes · doi:10.1016/j.pcd.2024.03.005 · Cited by 34 · see citing works
Hu, P., Zeng, X. Y., Zou, Z., Tang, W., Guo, Y., Yuan, Z.-L., Shi, P., Tan, Y. T., Song, Y., Shi, Y., et al. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-20-263 · Cited by 34 · see citing works
Dong, H., Zhao, Y., Teng, H., Jiang, T. X., Yue, Y., Zhang, S., Fan, L., Yan, M., & Shao, S. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118468 · Cited by 33 · see citing works
Marchesini, G., Bugianesi, E., Burra, P., Marra, F., Miele, L., Alisi, A., Vajro, P., Masarone, M., Petta, S., Persico, M., et al. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.04.029 · Cited by 33 · see citing works
Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease
Zhao, M., Xie, H., Shan, H., Zheng, Z., Li, G., Li, M., & Hong, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031102 · Cited by 31 · see citing works
Nutrition as Therapy in Liver Disease.
Shah, N., & Barritt, A. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2022.04.012 · Cited by 24 · see citing works
Choochuay, K., Kunhapan, P., Puangpetch, A., Tongsima, S., Srisawasdi, P., Sobhonslidsuk, A., Sungkanuparph, S., Biswas, M., & Sukasem, C. (2024) · World Journal of Hepatology · doi:10.4254/wjh.v16.i3.452 · Cited by 31 · see citing works
Chen, Y., Zhang, H., Chen, Y., Zhang, Y., Shen, M., Jia, P., Ji, S., & Wang, T. Z. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000105 · Cited by 31 · see citing works
The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum
Vidal‐Cevallos, P., Sorroza-Martínez, A. P., Chávez-Tapia, N. C., Uribe, M., Montalvo-Jave, E. E., & Nuño‐Lámbarri, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084397 · Cited by 32 · see citing works
Fatty liver in pregnancy: a narrative review of two distinct conditions
Azzaroli, F., Mazzella, G., Marchesini, G., Brodosi, L., & Petroni, M. L. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2020.1715210 · Cited by 30 · see citing works
Zou, Y., & Qi, Z. (2020) · Mediators of Inflammation · doi:10.1155/2020/6412916 · Cited by 29 · see citing works
Zhang, X.-L., Wang, T.-Y., Targher, G., Byrne, C. D., & Zheng, M. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0048 · Cited by 31 · see citing works
Authors, & Collaborators: (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1880-2388 · Cited by 30 · see citing works
Eslam, M., Chen, F., & George, J. (2020) · Clinical Liver Disease · doi:10.1002/cld.930 · Cited by 29 · see citing works
Huang, Z.-M., Ng, K., Chen, H.-Y., Deng, W., & Li, Y.-B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.739875 · Cited by 28 · see citing works
Qiu, S., Chen, J., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Nutrients · doi:10.3390/nu14132749 · Cited by 28 · see citing works
- Authors
- Wong, V. W.-S., Wong, G. L.-H., Chan, R. S.-M., Shu, S. S.-T., Cheung, B. H.-K., Li, L. S., Chim, A. M.-L., Chan, C. K.-M., Leung, J. K.-Y., Chu, W. C.-W., Woo, J., & Chan, H. L.-Y.
- Affiliations
- Chinese University of Hong Kong (HK)
- Corresponding author
- Chan, Henry Lik-Yuen
- ORCID
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2018-12
- Volume
- 69
- Issue
- 6
- Pages
- 1349-1356
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2888552653
- Cited by
- 319
- References
- 35
- Citations by year
- 2026: 27 · 2025: 39 · 2024: 62 · 2023: 54 · 2022: 40 · 2021: 45 · 2020: 31 · 2019: 18 · 2018: 1 · 2014: 1
- FWCI
- 18.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- non-alcoholic fatty liver disease, non-obese patients, lifestyle intervention, physical activity, weight loss, intrahepatic triglyceride, waist circumference, predictors of treatment response, community-based patients, long-term follow-up, weight maintenance, 1H NMR
- MeSH terms
- Adult, Aged, Diet, Female, Follow-Up Studies, Humans, Life Style, Male, Middle Aged, Obesity, Prospective Studies, Remission Induction, Triglycerides, Weight Loss, Exercise, Body Mass Index, Single-Blind Method, Treatment Outcome, Waist Circumference, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
